489 related articles for article (PubMed ID: 24315827)
1. Mechanisms of obesity-induced gastrointestinal neoplasia.
Alemán JO; Eusebi LH; Ricciardiello L; Patidar K; Sanyal AJ; Holt PR
Gastroenterology; 2014 Feb; 146(2):357-373. PubMed ID: 24315827
[TBL] [Abstract][Full Text] [Related]
2. Nutrition in the prevention of gastrointestinal cancer.
van den Brandt PA; Goldbohm RA
Best Pract Res Clin Gastroenterol; 2006; 20(3):589-603. PubMed ID: 16782531
[TBL] [Abstract][Full Text] [Related]
3. Role of insulin-like growth factor-binding proteins in the pathophysiology and tumorigenesis of gastroesophageal cancers.
Kashyap MK
Tumour Biol; 2015 Nov; 36(11):8247-57. PubMed ID: 26369544
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal study of insulin-like growth factor, insulin-like growth factor binding protein-3, and their polymorphisms: risk of neoplastic progression in Barrett's esophagus.
Siahpush SH; Vaughan TL; Lampe JN; Freeman R; Lewis S; Odze RD; Blount PL; Ayub K; Rabinovitch PS; Reid BJ; Chen C
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2387-95. PubMed ID: 18006928
[TBL] [Abstract][Full Text] [Related]
5. Obesity-associated digestive cancers: A review of mechanisms and interventions.
Zheng J; Zhao M; Li J; Lou G; Yuan Y; Bu S; Xi Y
Tumour Biol; 2017 Mar; 39(3):1010428317695020. PubMed ID: 28351315
[TBL] [Abstract][Full Text] [Related]
6. Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma.
Yen CJ; Izzo JG; Lee DF; Guha S; Wei Y; Wu TT; Chen CT; Kuo HP; Hsu JM; Sun HL; Chou CK; Buttar NS; Wang KK; Huang P; Ajani J; Hung MC
Cancer Res; 2008 Apr; 68(8):2632-40. PubMed ID: 18413730
[TBL] [Abstract][Full Text] [Related]
7. Alteration of the esophageal microbiota in Barrett's esophagus and esophageal adenocarcinoma.
Lv J; Guo L; Liu JJ; Zhao HP; Zhang J; Wang JH
World J Gastroenterol; 2019 May; 25(18):2149-2161. PubMed ID: 31143067
[TBL] [Abstract][Full Text] [Related]
8. IGF-1 and its receptor in esophageal cancer: association with adenocarcinoma and visceral obesity.
Doyle SL; Donohoe CL; Finn SP; Howard JM; Lithander FE; Reynolds JV; Pidgeon GP; Lysaght J
Am J Gastroenterol; 2012 Feb; 107(2):196-204. PubMed ID: 22146489
[TBL] [Abstract][Full Text] [Related]
9. The esophagitis to adenocarcinoma sequence; the role of inflammation.
Kavanagh ME; O'Sullivan KE; O'Hanlon C; O'Sullivan JN; Lysaght J; Reynolds JV
Cancer Lett; 2014 Apr; 345(2):182-9. PubMed ID: 23994342
[TBL] [Abstract][Full Text] [Related]
10. Sequence alterations of insulin-like growth factor binding protein 3 in neoplastic and normal gastrointestinal tissues.
Zou T; Fleisher AS; Kong D; Yin J; Souza RF; Wang S; Smolinski KN; Abraham JM; Meltzer SJ
Cancer Res; 1998 Nov; 58(21):4802-4. PubMed ID: 9809981
[TBL] [Abstract][Full Text] [Related]
11. Role of adipokines and cytokines in obesity-associated breast cancer: therapeutic targets.
Khan S; Shukla S; Sinha S; Meeran SM
Cytokine Growth Factor Rev; 2013 Dec; 24(6):503-13. PubMed ID: 24210902
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms behind the link between obesity and gastrointestinal cancers.
Tilg H; Moschen AR
Best Pract Res Clin Gastroenterol; 2014 Aug; 28(4):599-610. PubMed ID: 25194178
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor-I receptor blockade reduces the invasiveness of gastrointestinal cancers via blocking production of matrilysin.
Adachi Y; Li R; Yamamoto H; Min Y; Piao W; Wang Y; Imsumran A; Li H; Arimura Y; Lee CT; Imai K; Carbone DP; Shinomura Y
Carcinogenesis; 2009 Aug; 30(8):1305-13. PubMed ID: 19493905
[TBL] [Abstract][Full Text] [Related]
14. Gut microbiota-mediated inflammation in obesity: a link with gastrointestinal cancer.
Cani PD; Jordan BF
Nat Rev Gastroenterol Hepatol; 2018 Nov; 15(11):671-682. PubMed ID: 29844585
[TBL] [Abstract][Full Text] [Related]
15. Insulin promotes HER2 signaling activation during Barrett's Esophagus carcinogenesis.
Arcidiacono D; Antonello A; Fassan M; Nucci D; Morbin T; Agostini M; Nitti D; Rugge M; Alberti A; Battaglia G; Realdon S
Dig Liver Dis; 2017 Jun; 49(6):630-638. PubMed ID: 28185837
[TBL] [Abstract][Full Text] [Related]
16. Link of obesity and gastrointestinal cancer: crossroad of inflammation and oxidative stress.
Yang XD; Jiang S; Wang G; Zhang R; Zhang J; Zhu JS
J Biol Regul Homeost Agents; 2015; 29(4):755-60. PubMed ID: 26753635
[TBL] [Abstract][Full Text] [Related]
17. The effect of IGF-I receptor blockade for human esophageal squamous cell carcinoma and adenocarcinoma.
Adachi Y; Ohashi H; Imsumran A; Yamamoto H; Matsunaga Y; Taniguchi H; Nosho K; Suzuki H; Sasaki Y; Arimura Y; Carbone DP; Imai K; Shinomura Y
Tumour Biol; 2014 Feb; 35(2):973-85. PubMed ID: 24026884
[TBL] [Abstract][Full Text] [Related]
18. Role of bile acids in carcinogenesis of pancreatic cancer: An old topic with new perspective.
Feng HY; Chen YC
World J Gastroenterol; 2016 Sep; 22(33):7463-77. PubMed ID: 27672269
[TBL] [Abstract][Full Text] [Related]
19. Prospective study of self-reported diabetes and risk of upper gastrointestinal cancers.
Lin SW; Freedman ND; Hollenbeck AR; Schatzkin A; Abnet CC
Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):954-61. PubMed ID: 21415356
[TBL] [Abstract][Full Text] [Related]
20. Obesity and metabolic syndrome: pathological effects on the gastrointestinal tract.
Feakins RM
Histopathology; 2016 Apr; 68(5):630-40. PubMed ID: 26599607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
